Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Sep 26, 2025
Episode
322
Soundcloud
Share
This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer.
Guest
Cheryl Ho
MD, FRCPC
Thoracic Oncologist, BC Cancer
Clinical Associate Professor and Fellowship Program Director
Maria Velez Velez
MD, MS
Clinical Instructor, Division of Hematology-Oncology
UCLA David Geffen School of Medicine
